HEATR3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.638400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.826200E-01
Normal-vs-Stage2
1.869810E-01
Normal-vs-Stage3
4.388400E-02
Normal-vs-Stage4
5.267000E-01
Stage1-vs-Stage2
6.333200E-01
Stage1-vs-Stage3
1.597720E-02
Stage1-vs-Stage4
9.058600E-01
Stage2-vs-Stage3
7.495500E-02
Stage2-vs-Stage4
6.175400E-01
Stage3-vs-Stage4
9.456200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.792800E-01
Normal-vs-AfricanAmerican
7.001800E-01
Normal-vs-Asian
7.492100E-02
Caucasian-vs-AfricanAmerican
4.169600E-01
Caucasian-vs-Asian
6.103700E-02
AfricanAmerican-vs-Asian
8.868200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.833810E-01
Normal-vs-Female
3.894600E-01
Male-vs-Female
2.104400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.039200E-01
Normal-vs-Age(41-60Yrs)
3.087800E-01
Normal-vs-Age(61-80Yrs)
2.595800E-01
Normal-vs-Age(81-100Yrs)
3.338400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.557600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.126200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.007800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.525570E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.601400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.738000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.681600E-01
Normal-vs-Daily Drinker
3.322400E-02
Normal-vs-Weekly Drinker
2.100800E-01
Normal-vs-Occasional Drinker
7.545600E-01
Normal-vs-Social Drinker
6.132000E-01
Non Drinker-vs-Daily Drinker
1.095840E-01
Non Drinker-vs-Weekly Drinker
9.425000E-01
Non Drinker-vs-Occasional Drinker
3.040000E-01
Non Drinker-vs-Social Drinker
1.051820E-01
Daily Drinker-vs-Weekly Drinker
2.162000E-01
Daily Drinker-vs-Occasional Drinker
6.152400E-02
Daily Drinker-vs-Social Drinker
4.555600E-03
Weekly Drinker-vs-Occasional Drinker
3.238000E-01
Weekly Drinker-vs-Social Drinker
1.625750E-01
Occasional Drinker-vs-Social Drinker
9.606400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.227200E-01
Normal-vs-Grade 2
7.510800E-01
Normal-vs-Grade 3
7.201600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.527600E-01
Grade 1-vs-Grade 3
8.844200E-01
Grade 1-vs-Grade 4
5.227200E-01
Grade 2-vs-Grade 3
4.911200E-01
Grade 2-vs-Grade 4
7.510800E-01
Grade 3-vs-Grade 4
7.201600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.276000E-01
Normal-vs-NonDiabetic
2.399800E-01
Diabetic-vs-NonDiabetic
9.012000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.154400E-01
Normal-vs-NoPancreatitis
2.608000E-01
Pancreatitis-vs-NoPancreatitis
5.737400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.507400E-01
Normal-vs-N1
1.798040E-01
N0-vs-N1
5.859000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.203560E-01
Normal-vs-TP53-NonMutant
4.725600E-01
TP53-Mutant-vs-TP53-NonMutant
1.559200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
